TRANSHUMAN CAPITAL

Summary

Transhuman Capital invests in therapeutics, medical devices, and other technologies that have the potential to fundamentally improve the human condition.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 293 M

Avg. Deal Size£ 146 M

Market Context

Senior Management

Amanda Johnstone
CEO
CR Sincock
Founder

Sort

16 May 2022|United States|Software

Target: KRIYA THERAPEUTICS INC

Bidder: NARYA CAPITAL

13 Service Providers

3 Target | 10 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 220 M

Value

14 Jul 2021|United States|Software

Target: KRIYA THERAPEUTICS INC

Bidder: WOODLINE PARTNERS

14 Service Providers

2 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 72 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy